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Anxious and non-anxious forms of major depression:
familial, personality and symptom characteristics
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Background. Earlier clinical studies have suggested consistent differences between anxious and non-anxious depression.
The aim of this study was to compare parental pathology, personality and symptom characteristics in three groups of
probands from the general population: depression with and without generalized anxiety disorder (GAD) and with
other anxiety disorders. Because patients without GAD may have experienced anxious symptoms for up to 5 months,
we also considered GAD with a duration of only 1 month to produce a group of depressions largely unaffected by
anxiety.
Method. Depressive and anxiety disorders were assessed in a 10-year prospective longitudinal community and family
study using the DSM-IV/M-CIDI. Regression analyses were used to reveal associations between these variables and with
personality using two durations of GAD: 6 months (GAD-6) and 1 month (GAD-1).
Results. Non-anxious depressives had fewer and less severe depressive symptoms, and higher odds for parents with
depression alone, whereas those with anxious depression were associated with higher harm avoidance and had parents
with a wider range of disorders, including mania.
Conclusions. Anxious depression is a more severe form of depression than the non-anxious form; this is true even when
the symptoms required for an anxiety diagnosis are ignored. Patients with non-anxious depression are different from
those with anxious depression in terms of illness severity, family pathology and personality. The association between
major depression and bipolar disorder is seen only in anxious forms of depression. Improved knowledge on different
forms of depression may provide clues to their differential aetiology, and guide research into the types of treatment
that are best suited to each form.
Received 17 April 2013; Revised 12 June 2013; Accepted 15 June 2013; First published online 1 August 2013
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Introduction
The DSM-5 classification of major depressive disorder
(MDD) now requires clinicians to complete an ‘anxiety
specifier’ that will in effect distinguish between those
depressed individuals whose depression is unaccom-
panied by anxiety from those with anxious symptoms
accompanying their depressive state. It is therefore
timely to consider what is known about anxious and
non-anxious forms of depressive illness.
For many years, clinicians have been aware that
there is an anxious form of depression that has distinc-
tive features from depression without anxiety (Raskin
et al. 1974; Fawcett & Kravitz, 1983). At the time of
the National Institute of Mental Health (NIMH)
Collaborative Depression Study, Clayton et al. (1991)
described distinctive features of anxious forms of
depression in terms of both family history and course,
using a six-item anxiety scale in addition to the usual
assessment of depression. Individuals with anxious
depression were more likely than those with non-
anxious depression to reveal increased familial aggre-
gation among first-degree relatives (FDRs) diagnosed
with major depression, unipolar depression and
primary depression, and were shown to have a
worse prognosis than those with pure depression. In
a small family history study, Coryell et al. (1992)
showed that depressives with panic attacks had more
FDRs with phobic disorders than non-anxious depress-
ives, but no excess of FDRs with generalized anxiety
disorder (GAD) or panic disorders. Reich (1993)
showed that the FDRs of anxious depressives were
more likely to be cases of major depression, but
showed that they also more often met criteria for alco-
hol abuse, anxious personality and dramatic personal-
ity than pure depressives or controls.
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Fava et al. (2000) reported a series of 255 patients
with depression and pointed out that a variety of
anxiety disorders were co-morbid with the depression
in just over 50% of the cases. Social phobia or GAD had
preceded the episode of depression in 63% of the cases
of depression. In the Sequenced Treatment Alterna-
tives to Relieve Depression (STAR*D) study (Fava
et al. 2003, 2004, 2008), 46% of the patients studied
had anxious depression, and these cases tended be
older, more likely to be unemployed, and to have
had fewer years in education compared to cases of
non-anxious depression. There were also fewer males
and fewer ‘never married’. All these studies used
short scales to measure current anxiety symptoms.
When either major depression or bipolar disorder
(BPD) is accompanied by anxious symptoms, the out-
look is worse and the probability of suicide is higher
(Goldberg & Fawcett, 2012).
Over the past two decades additional evidence has
become available from prospective community cohort
studies, partially also including data on the familial
aggregation. Wittchen et al. (2000, 2010) found in
the Early Developmental Stages of Psychopathology
(EDSP) cohort that incident anxiety disorders over a
period 10 years have an increased odds of secondary
depressive disorders, and concluded that anxiety
disorders are primary disorders that increase the risk
of later depression. Depression, however, can also
occur without anxiety (Moffitt et al. 2007b; Beesdo-
Baum et al. 2010a).
Beesdo-Baum et al. (2010b), usingmatchedcumulative
lifetime analyses, compared the morbidity patterns in
the parents of four groups of probands: those with
GAD, depression only, anxiety only, and co-morbid
depression and ‘any anxiety disorder’. Those with
GAD were allowed to have other co-morbidities but
GAD was excluded in the other three groups. Thus
‘anxiety and depressive disorder’ does not mean
co-morbid MDD and GAD. This study highlights
the importance of examining ‘other anxiety disorders’
(notably panic and phobic disorders) because these
were found tobe longitudinallyassociatedwithdepress-
ive disorders as strongly as GAD. These disorders
should therefore also be taken into account as familial
disorders that may be associated with either anxious or
non-anxious forms of depression in offspring.
Given that there is a strong genetic relationship
between MDD and GAD (Kendler et al. 1992;
Hettema, 2008), and that some structural models
using higher-order factor analytic methods group
GAD along with distress disorders and not with fear
disorders (Krueger 1999; Vollebergh et al. 2001; Slade
& Watson, 2006), if these disorders are to be arranged
in a hierarchy, MDD+GAD would be above MDD
+panic and phobic disorders. It has also been shown
that with GAD defined as lasting 6 months (GAD-6),
cross-sectionally negative affect is common to both
(Goldberg et al. 2009), and that each disorder can be
followed by the other (Moffitt et al. 2007b), there are
clear grounds for giving GAD the prime position as
a co-morbid disorder, but then considering MDD
co-morbid with ‘other anxiety disorders’, this time
excluding MDD. All these disorders experience
anxiety, and there is therefore a need to consider all
of them when examining the effects of anxious symp-
toms on depression.
In summary, prospective longitudinal data confirm
that any preceding anxiety disorder seems to be associ-
ated with increased risk of depression and a more
malignant course, but that a substantial number of
cases of major depression do not report any anxiety.
The EDSP study can be used to compare the types of
parental psychopathology that are associated with
three groups of offspring: those with depression with-
out GAD-6, those with depression with ‘other anxiety
disorders’, and those with MDD co-morbid with
GAD-6.
Given prior findings that a considerable proportion
of individuals experience GAD of less than 6 months
duration (Ruscio et al. 2007; Goldberg et al. 2009), to
produce a group of patients with MDD with as few
anxious symptoms as possible it was also necessary
to use a definition of GAD with a duration of only
1 month (GAD-1). This would eliminate cases that
had in fact had anxious symptoms for between
1 month and 6 months, and so produce a group of
depressives that more nearly approached the non-
anxious depressives of the studies discussed earlier.
By reducing the duration of anxious symptoms to
1 month, the prevalence of ‘co-morbid’ MDD and
GAD-1 would increase considerably while that of
‘MDD only’ would decrease (Kessler et al. 2005;
Goldberg et al. 2011).
The aim of this study was therefore to describe the
familial and personality characteristics of depression
of three groups of depressed patients with GAD
defined as lasting only 1 month: depression without
GAD-1, depression with panic or phobic disorders,
and depression with GAD-1. The hypotheses being
tested were, first, that anxious depressives would
come from parents with a wider range of disorders
than non-anxious depressives, second that anxious
depressives would have greater scores on harm avoid-
ance than non-anxious depressives, and third that
anxious depression would be a more severe form of
depression, even if anxious symptoms are ignored.
Recognition of these different forms of depression
may encourage research into the forms of treatment
that are best suited to each form, and may also provide
clues to the aetiology of each.
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Method
Sample
The prospective longitudinal EDSP study assessed
mental disorders and associated risk factors in a repre-
sentative sample of 3021 adolescents and young adults
aged 14 to 24 years at baseline (T0). The study also
includes follow-up surveys (T1, T2 and T3), a family
history component (T0, T2 and T3) and parent surveys
(T1 and T3). Study methods and design and infor-
mation on representativeness and response rates have
been described previously (Wittchen et al. 1998b,c).
The baseline sample was selected in 1994 from gov-
ernment registries (greater Munich area, Germany).
The study emphasized development by sampling
14–15-year-old individuals at twice the probability
and 22–24-year-old individuals at half the probability
of 16–21-year-old individuals. Sample weights account
for this sampling scheme in the subsequent analyses.
In total, 3021 interviews [response rate (RR) 70.9%]
were conducted at baseline (T0). At T1 (range 1.2–2.1
years after baseline), 1228 interviews (RR 88.0%)
were conducted among participants aged 14–17 years
at baseline. At T2 (range 2.8–4.1 years after baseline),
2548 participants (RR 84.3%) were interviewed;
and 2210 (RR 73.2%) were interviewed at T3 (range
7.3–10.6 years after baseline). The overall conditional
follow-up RR of 92% (n=2797) for at least one
follow-up assessment compares favourably to other
studies (Fergusson & Horwood, 2001; Bittner et al.
2007). There was no selective attrition from baseline
to the 10-year follow-up assessment for participants
with any of the disorders considered.
Diagnostic assessment
Face-to-face interviews were conducted by trained
clinical interviewers using the computer-assisted
Munich-Composite International Diagnostic Interview
(DIA-X/M-CIDI; Wittchen & Pfister, 1997). At baseline,
the lifetime version of the DIA-X/M-CIDI was used,
at follow-up the interval version. All diagnoses were
obtained using M-CIDI/DSM-IV algorithms. For the
purposes of the current study, the depression exclusion
criterion was not applied for the diagnosis of GAD.
The impairment criterion for phobias was applied
when respondents were aged 518 years (Wittchen
et al. 1999).
Aggregated diagnostic data from T0 to T3 were used
to generate three single diagnoses of MDD: ‘MDD and
GAD’, ‘MDD and other anxiety disorders’ (comprising
panic disorder, agoraphobia, specific phobia and social
phobia, but no GAD) and ‘MDD only’ (no GAD and no
other anxiety disorder). Consistent with explorations
on duration criteria (Beesdo-Baum et al. 2007, 2011),
two definitions of GAD were considered, one with
a duration of 6 months (GAD-6) and the other with a
duration of 1 month (GAD-1), so as to produce
a group of ‘MDD only’ uncontaminated with anxiety
lasting between 1 and 6 months.
The test–retest reliability ranged from κ=0.45
for GAD to κ=1.00 for panic disorder (Wittchen et al.
1998a). Inconsistencies in GAD were mainly due
to different responses with regard to the 6-month
duration; retest reliability of the GAD stem question,
asking for anxiety/worry of 1 month or more, however,
was good and in the range of other disorders (κ=0.70).
The validity of the DSM-IV/M-CIDI diagnoses com-
pared to independent clinical consensus diagnoses by
treating physicians was estimated, with κ ranging
from 0.79 for any anxiety disorder including GAD to
0.96 for a major depressive episode (Reed et al. 1998).
Parental psychopathology
Parental diagnoses were based on two sources:
direct interviews with the parent using the identical
diagnostic interview and algorithms as in the off-
spring, and family history information provided by
the offspring. Interviewed parents (n=1192) under-
went the same assessment procedures as their off-
spring (DIA-X/M-CIDI). Family history items were
designed using a modified version of the Family
History Research Diagnostic Criteria (FH-RDC) as a
model (Merikangas et al. 1998). At T0, DIA-X/M-CIDI
stem questions and questions about treatment were
used; at T2 and T3, an extended family history module
covered DSM-IV criteria. Parental disorders were
aggregated using a priority hierarchy that was deter-
mined following examination of agreement patterns
between family history report and available parent
interview data (Beesdo-Baum et al. 2007). If direct
information was available, it was used. If direct infor-
mation was not available, family history information
from T3, then T2, and lastly T0 was used.
In the current study we considered the same diag-
nostic hierarchy for parental disorders (either parent)
as for offspring disorders, with the exception that
mania was considered at the top of the hierarchy, so
as to examine relationships outside the confines of
MDD and anxiety diagnoses.
Offspring personality characteristics
The German version of Cloninger’s 100-item Tridimen-
sional Personality Questionnaire (TPQ; Cloninger,
1997; Lieb et al. 2002) was used at T3 (available for n
=2181) to assess three distinct dimensions: novelty
seeking, reward dependence and harm avoidance.
Novelty seeking reflects exploratory activity and aver-
sion to monotony whereas reward dependence is
Anxious and non-anxious forms of major depression 1225
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characterized by the maintenance of reward-inducing
behaviour and the reduction of punishment-eliciting
behaviour. Harm avoidance indicates the tendency
towards behavioural inhibition to avoid punishment,
novel stimuli and non-reward. The TPQ is based on
Cloninger’s general theory of personality and is con-
ceptualized to measure stable traits by self-report.
Reliability and construct validity of the German ver-
sion indicate sufficient psychometric properties
(Weyers et al. 1995).
Statistical procedures
Data analyses were conducted using Stata Release 12.1
(StataCorp, 2012). Data are weighted by age, sex and
geographical location at baseline to match the distri-
bution of the sampling frame; frequencies (numbers)
are reported unweighted. For each offspring diagnosis
(MDD alone, MDD+other anxiety disorders, MDD
+GAD), the association in the form of an odds ratio
(OR) with parental history of psychopathology was
examined using multinomial logistic regression ana-
lyses. In addition, comparisons were made between
MDD alone and MDD+other anxiety disorders, and
MDD alone and MDD+GAD. Associations with per-
sonality characteristics of each disorder were calcu-
lated using linear regression analyses. Standardized
TPQ scores (mean=0, standard deviation=1) were
used to reveal standardized mean differences
(SMDs). All analyses were adjusted for sex and age.
Results
Prevalence and sample characteristics
The overall prevalences for the offspring diagnoses are
shown in Table 1, for both 1- and 6-month definitions
of GAD. The shorter duration of GAD allows the
group of MDD alone and MDD+other anxiety
disorders to be reduced but the groups with GAD
and MDD+GAD to increase.
The mean age of the MDD+GAD groups was on
average slightly higher (p<0.05) compared to the
MDD+anxiety disorder group for both GAD
definitions and compared to the MDD-alone group
for GAD-1 (Table 2). Both co-morbid MDD groups
had a higher proportion of females, an earlier age at
MDD onset and a higher mean number of MDD symp-
toms than the group with MDD alone (p<0.05). More
than half of the cases in the MDD+GAD groups
revealed co-morbidity with other anxiety disorders
(GAD-6: n=40/60, 68.8%; GAD-1: n=80/136, 57.2%).
The next step was to compare the three groups in
terms of the frequencies of depressive symptoms as
derived from the M-CIDI depression section (i.e. ignor-
ing the anxiety symptoms that characterized the
anxiety diagnoses). Table 2 shows that a broad range
of depression symptoms, including severe symptoms
such as suicidal ideation and complete loss of interest
and pleasure, occur more commonly in the depression
plus ‘other anxiety disorders’ group than in the
depression-only group (Fava et al. 2004). Furthermore,
particularly severe symptoms such as early morning
waking, weight loss, psychomotor retardation, diurnal
variation of mood and guilt are added to the list when
considering MDD+GAD-1.
Parental psychopathology
Table 3 shows the frequency of parental diagnoses for
the three disorders among offspring (MDD only; MDD
+other anxiety disorders, and MDD+GAD) for GAD as
defined with a duration of 6 months and for GAD with
a duration of only 1 month. The associations indicate
that, whereas offspring with MDD alone have higher
odds of parents with either MDD alone or MDD
+other anxiety disorders, the other two disorders are
each associated with a range of anxiety diagnoses.
When MDD+other anxiety disorders is compared
Table 1. Prevalences of disorder groups with the duration of generalized anxiety disorder (GAD) set at 6 months (GAD-6) and
1 month (GAD-1) (n=3021)
Other anxiety
disorders alone
GAD alone
(including other
anxiety disorders) MDD alone
MDD and
other anxiety
disorders MDD and GAD
n %w n %w n %w n %w n %w
GAD-6 459 13.4 46 1.8 359 13.1 204 6.5 60 2.1
GAD-1 414 12.1 138 5.2 323 11.7 164 5.2 136 4.8
MDD, Major depressive disorder; n, unweighted number; %w, weighted percentage.
Other anxiety disorders include panic disorder, agoraphobia, social phobia and specific phobia.
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Table 2. Sample characteristics and depression symptom profile in the three diagnostic groups with the duration of generalized anxiety disorder (GAD) set at 6 months (GAD-6) and
1 month (GAD-1) (n=3021)
Sample characteristics/
symptom profile
Offspring disorder groups (GAD-6) Offspring disorder groups (GAD-1)
(1) MDD alone
(n=359)
(2) MDD and other
anxiety disorders
(n=204) 2>1
(3) MDD and
GAD-6 (n=60) 3>1
(1) MDD
alone
(n=323)
(2) MDD and
other anxiety
disorders (n=164) 2>1
(3) MDD and
GAD-1 (n=136) 3>1
Agea (years), mean (S.D.) 27.2 (3.9) 26.5 (4.0) 28.3 (3.5) * 27.1 (4.0) 26.5 (4.0) 27.7 (3.6)
Female sex, n (%w) 192 (55.5) 146 (71.3) * 42 (72.0) * 173 (55.9) 111 (67.3) * 96 (70.5) *
Age at onset of MDD (years), mean (S.D.) 19.3 (4.7) 17.8 (4.9) * 17.3 (5.3) * 19.4 (4.8) 18.1 (4.7) * 17.5 (5.1) *
No. of MDD symptom criteria met, mean (S.D.) 6.5 (1.2) 7.0 (1.3) * 7.3 (1.3) * 6.5 (1.2) 7.0 (1.2) * 7.2 (1.3) *
MDD criteria symptoms, n (%w)
1. Depressed mood 348 (97.3) 195 (95.8) 60 (100.0) 313 (97.2) 155 (94.8) 135 (99.3)
2. Markedly diminished interest or pleasure 261 (73.7) 168 (84.8) * 49 (78.6) 231 (72.6) 134 (83.9) * 113 (82.3) *
3. Weight loss 117 (33.4) 85 (41.8) 29 (56.1) * 104 (32.4) 69 (42.7) 58 (47.1) *
3. Significant weight gain 31 (8.0) 26 (14.1) 16 (23.9) * 29 (8.3) 19 (13.2) 25 (16.7) *
3. Decrease in appetite 195 (55.8) 119 (62.1) 34 (59.9) 174 (54.7) 94 (61.3) 80 (63.2)
3. Increase in appetite 90 (24.5) 68 (30.2) 28 (45.7) * 85 (26.0) 56 (30.6) 45 (31.1)
4. Insomnia: difficulty falling asleep 217 (59.4) 127 (61.2) 43 (72.3) 188 (56.9) 102 (61.0) 97 (71.7) *
4. Insomnia: difficulty staying asleep 173 (49.1) 118 (59.1) * 39 (65.5) 151 (47.0) 91 (57.7) * 88 (65.6) *
4. Insomnia: early awakening 124 (34.4) 91 (42.1) 27 (45.8) 106 (32.2) 71 (41.0) 65 (48.1) *
4. Hypersomnia 139 (39.4) 101 (50.5) * 27 (40.0) 125 (39.5) 76 (47.3) 66 (46.0)
5. Psychomotor retardation (observed by others) 56 (15.9) 41 (20.2) 19 (32.6) * 50 (15.2) 36 (21.1) 30 (25.2) *
5. Psychomotor agitation 98 (28.3) 56 (26.9) 22 (40.6) 92 (30.1) 44 (26.3) 40 (29.7)
6. Fatigue or loss of energy 235 (66.1) 158 (77.8) * 52 (83.0) * 206 (64.3) 123 (75.6) * 116 (83.3) *
7. Feelings of worthlessness 149 (39.9) 114 (55.8) * 44 (73.7) * 130 (38.2) 82 (49.5) 95 (70.0) *
7. Feelings of inferiority 152 (42.0) 127 (60.4) * 42 (71.9) * 137 (42.2) 98 (56.6) * 86 (63.8) *
7. Low self-confidence 90 (23.2) 79 (41.0) * 32 (58.5) * 76 (20.8) 64 (40.7) * 61 (49.7) *
7. Excessive or inappropriate guilt 122 (31.5) 85 (43.2) * 27 (47.9) * 110 (31.9) 65 (41.3) 59 (43.1) *
8. Diminished ability to concentrate 309 (85.9) 183 (89.7) 54 (87.8) 275 (84.6) 145 (88.4) 126 (92.4)
8. Diminished ability to think (slow thoughts) 212 (57.7) 142 (68.6) * 45 (69.5) 189 (57.0) 114 (68.9) * 96 (67.3)
8. Problems to remember things 61 (16.1) 43 (20.9) 25 (44.4) * 53 (15.2) 33 (19.5) 43 (33.4) *
8. Indecisiveness 132 (37.5) 114 (58.5) * 39 (63.8) * 112 (34.9) 84 (53.6) * 89 (66.5) *
9. Thoughts of death 229 (61.2) 146 (71.9) * 44 (73.2) 205 (61.0) 117 (70.2) 97 (71.6)
9. Wish to die 93 (24.7) 86 (41.4) * 34 (54.6) * 82 (24.2) 65 (38.9) * 66 (46.4) *
9. Suicidal thoughts 104 (28.3) 91 (41.4) * 31 (54.7) * 90 (26.8) 70 (39.6) * 66 (49.1) *
9. Suicidal plans 37 (9.7) 45 (21.1) * 17 (26.7) * 32 (8.9) 37 (21.4) * 30 (22.0) *
9. Suicidal attempts 26 (5.9) 18 (8.0) 10 (19.6) * 25 (6.5) 14 (7.9) 15 (11.2)
Other symptoms/severity indicators, n (%w)
Complete loss of interest 163 (44.2) 126 (61.7) * 39 (68.5) * 144 (42.7) 99 (59.8) * 85 (65.3) *
Complete loss of pleasure 161 (46.6) 113 (58.9) * 41 (71.6) * 142 (46.0) 85 (56.0) * 88 (65.7) *
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with MDD alone, only GAD alone (with or without
other anxiety disorders) has a significant OR, but
when MDD+GAD is compared with MDD alone, not
only those with GAD alone but also those with MDD
+GAD and mania have significantly raised ORs.
Given that symptom severity was higher in the
co-morbid groups, we additionally adjusted the com-
parison between the three MDD groups for symptom
severity (number of symptom criteria met). All associ-
ations remained significant, with the exception that the
OR for parental GAD alone was attenuated to non-
significance for the comparison of MDD+other anxiety
disorders and MDD alone without GAD-6.
Overall, it can be seen that it makes little dif-
ference whether GAD is considered with a duration
of 6 months or 1 month.
Offspring personality characteristics
Table 4 shows the mean values for the three groups of
offspring on the TPQ, for both the 6- and 1-month
definitions of GAD. It can be seen that there is a steady
increase in the mean value for harm avoidance from
MDD alone to MDD+other anxiety disorders to MDD
+GAD-6. The ORs for GAD-6 indicate that, although
harm avoidance is associated with increased odds of
all three disorders, with both MDD+other anxiety dis-
orders and MDD+GAD have significantly greater ORs
than MDD alone. The data are different for GAD-1:
MDD alone is now no longer more likely to be harm
avoidant, but is more likely to have a high value for
novelty seeking. Both of the other groups are more
likely to be harm avoidant, but the MDD+GAD-1
group is less likely to be novelty seeking than MDD
alone. For both GAD definitions, co-morbid MDD
+GAD is more likely to be reward dependent although
the comparison with MDD alone is only significant for
GAD-6. When the data are additionally adjusted for
the severity of MDD, the between-group associations
for GAD-6 attenuate to non-significance whereas the
other between-group associations remain significant.
Discussion
There are several very different, striking findings in
this study: first, it is clear that depression without an
anxiety diagnosis has fewer depressive symptoms
than anxious forms of depression, and when GAD-1
is present the additional symptoms are those associ-
ated with more severe forms of depressive illness. In
this way non-anxious depression emerges as the mild-
est form of depression, despite satisfying the criteria
for MDD, and depression accompanied by GAD-1 is
the most severe form. Depression accompanied by
panic or phobic disorders is intermediate in severityTa
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between these two, with nine symptoms that did not
discriminate between groups 2 and 1 but do discrimi-
nate between groups 3 and 1 (Table 2, for GAD-1)
One reason why people with MDD+GAD should be
more likely to have severe forms of depression than
non-anxious depressives is that a longitudinal study
(Moffitt et al. 2007a) has shown that cases of MDD
+GAD are distinguished by having more severe disad-
vantages in early life than either disorder on its own.
They not only have more symptoms, they also have
more risk factors.
There are differences between offspring with MDD
only and both the other groups in the odds of parental
pathology. Offspring with depression alone have
higher odds of having parents with MDD alone or
MDD with other anxiety diagnoses, whereas offspring
with MDD co-morbid with GAD are more likely to
have parents with a wider range of diagnoses, includ-
ing MDD+GAD and mania. These relationships are not
affected by whether the duration of GAD is 1 month or
6 months. The association with BPD is seen with
anxious forms of depression but not with non-anxious
forms. This finding fits in well with the importance of
anxiety in both MDD and BPD (Goldberg & Fawcett,
2012). It is also consistent with the demonstration by
Zimmerman et al. (2009) that suggests that MDD is a
heterogeneous concept including a large group of sub-
threshold BPD that is clinically significant and shares
similarities with BPD. It is not suggested that there is
a causal connection between parental pathology and
depression without anxiety; what is demonstrated is
an interesting association, open to the possibility that
there are either genetic or personality differences in
parents whose MDD is with or without anxiety.
There are also important differences in personality
associated with MDD when a shorter duration of
anxiety is considered for GAD because, compared
with the longer duration, those with MDD+GAD are
no longer more likely to be harm avoidant but are
more likely to have increased mean scores for novelty
seeking, whereas the association between co-morbid
MDD+GAD and reward dependence is unaffected by
the duration of anxiety. If GAD has its longer duration
of 6 months, then non-anxious depression is more
likely to be more harm avoidant than controls, in
that it reflects longer-term anxiety.
The finding that co-morbid cases have greater scores
on harm avoidance than MDD alone fits with the dem-
onstration that cases of both GAD and MDD in the
New Zealand cohort study had raised scores for nega-
tive emotionality relative to controls (Moffitt et al.
2007a), and is consistent with the National Co-
morbidity study follow-up where only GAD had
raised scores on neuroticism, whereas MDD on its
own had no such significant elevation relative to
controls (Beesdo-Baum et al. 2007). Thus harm avoid-
ance, which is partly genetically determined, might
be implicated in the findings reported; further research
is clearly indicated.
These findings complement earlier findings that
depression with anxiety has a worse prognosis, is
less responsive to treatment and has a higher suicide
rate (Goldberg & Fawcett, 2012). Depression unaccom-
panied by significant anxiety should be thought of as a
milder form of depressive illness with different charac-
teristics in both associated parental pathology and
personality. Depression accompanied by panic or
phobic disorders is more severe than depression
alone, even when the anxious symptoms are not
taken into account, and when depression is ac-
companied by generalized anxiety, this is the most
severe form of depression, irrespective of the duration
of anxiety. These findings are based on symptom
counts of depressive symptoms only, and take no
account of the anxiety symptoms that are also present
in the co-morbid groups.
At present, depression unaccompanied by anxiety
and anxious forms of depression are conflated by
our present classifications because each satisfies the
requirements for major depression. These differences
suggest that further research on the best treatments
for each might be fruitful.
From the viewpoint of the clinical meaning of these
findings, cases of depression without anxiety are fre-
quently apathetic and with low energy levels whereas
those with anxiety have symptoms related to higher
alerting. Marked apathy is not included in the CIDI
symptom list, and perhaps the depression encountered
in a community sample rarely reaches the severity of
cases treated by the mental health services, so account-
ing for the failure of retardation to appear as a charac-
teristic of non-anxious depression. The severe forms of
each are different: whereas the former is characterized
by apathy and may present as a retarded depression,
the latter may present as an agitated depression.
Thus, depression without anxiety may respond
selectively to alerting medications and activating
psychological therapies whereas anxious forms of
depression may respond better to sedating anti-
depressants. From a more theoretical perspective,
anxious forms are associated with harm avoidance
(or negative emotionality), and these have a wider
co-morbidity along with important links to BPD.
The present findings can be considered together
with emerging differences between the two disorders
in functional (Andreescu et al. 2009, 2011) and struc-
tural neuroimaging (Inkster et al. 2011), in neuropsy-
chiatric and sensory testing (Bruder et al. 1999;
Taylor Cliff et al. 2011; Nelson et al. 2012) and the endo-
crine system (Rao et al. 1989; Meller et al. 1995). These
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Table 3. Frequency of and association with parental mental disorders in the three diagnostic groups, with the duration of generalized anxiety disorder (GAD) set at 6 months (GAD-6) and
1 month (GAD-1) (n=3021)
Parental disordera n
Offspring disorders
MDD alone MDD and other anxiety disorders MDD and GAD-6
Comparisons between disordersa
No
(n=2662)
Yes
(n=359) Comparison
No
(n=2817)
Yes
(n=204) Comparison
No
(n=2961)
Yes
(n=60) Comparison
MDD and
other anxiety
disorders v.
MDD alone
MDD and
GAD-6 v.
MDD alone
%w %w OR 95% CI %w %w OR 95% CI %w %w OR 95% CI OR 95% CI OR 95% CI
No MDD or anxiety
disorder/GAD
1681 60.2 47.9 Ref. 59.7 42.2 Ref. 59.5 17.8 Ref. Ref. Ref.
Other anxiety
disorder alone
367 9.9 10.5 1.5 1.0–2.2 9.7 13.5 2.0* 1.2–3.3 9.9 15.1 6.3* 2.3–17.5 1.3 0.7–2.4 4.3*† 1.4–13.2
GAD alone 97 3.0 2.7 1.1 0.5–2.3 2.8 6.5 3.2* 1.7–6.2 2.9 5.4 6.1* 1.7–21.3 2.8* 1.1–6.8 6.2*† 1.6–24.8
MDD alone 394 12.8 20.9 2.0* 1.5–2.9 13.7 15.6 1.5 1.0–2.5 13.8 18.9 4.5* 1.7–11.6 0.7 0.4–1.3 2.6 1.0–7.2
MDD and other
anxiety disorders
216 5.5 8.8 2.2* 1.4–3.4 5.6 10.3 2.6* 1.5–4.5 6.0 4.5 2.9 0.8–10.7 1.3 0.7–2.4 1.4 0.3–5.7
MDD and GAD 187 5.9 7.1 1.5 0.9–2.5 5.8 9.4 2.1* 1.2–3.7 5.5 30.6 18.3* 7.5–44.7 1.5 0.7–3.0 12.8*† 4.7–34.7
Mania 79 2.7 2.1 1.0 0.5–2.3 2.6 2.5 1.4 0.6–3.3 2.5 7.7 12.1* 3.7–40.0 1.2 0.4–3.6 13.4*† 3.5–51.3
Parental disordera n
MDD alone MDD and other anxiety disorders MDD and GAD-1
Comparisons between disordersa
No
(n=2698)
Yes
(n=323) Comparison
No
(n=2857)
Yes
(n=164) Comparison
No
(n=2885)
Yes
(n=136) Comparison
MDD and
other anxiety
disorders
v. MDD alone
MDD and
GAD-1
v. MDD alone
%w %w OR 95% CI %w %w OR 95% CI %w %w OR 95% CI OR 95% CI OR 95% CI
No MDD or anxiety
disorder/GAD
1681 59.9 48.4 Ref. 59.5 41.2 Ref. 59.9 33.0 Ref. Ref. Ref.
Other anxiety
disorder alone
367 9.9 10.5 1.4 0.9–2.2 9.8 13.2 2.0* 1.2–3.4 9.8 13.8 3.0* 1.5–5.8 1.4 0.7–2.6 2.0 0.9–4.2
GAD alone 97 3.1 2.0 0.8 0.3–1.8 2.8 6.7 3.4* 1.6–6.9 2.8 6.5 4.1* 1.9–9.0 4.0*† 1.4–11.6 5.3*† 1.8–15.3
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findings, taken together with the data presented earl-
ier, may shed further light on the differences between
these two forms of depressive illness.
Limitations
First, the EDSP study did not include a group of
depressives without anxious symptoms whereas our
group of ‘depression alone’ contains cases of dep-
ression with anxious symptoms that have lasted up
to 4 weeks. This cannot be avoided with the present
dataset, but could readily be addressed in future
research. Second, there are limitations imposed by
the relatively small numbers of cases of GAD and
mania, despite the fairly large population sample.
Conclusions
Despite these limitations, our findings support the
view that if current anxious symptoms are considered
rather than long-standing anxious symptoms, anxious
depression is a more severe form of depression. This
remains true even if the anxious symptoms are
ignored. The anxiety specifier recommended in
DSM-5 is a way of directing the clinician’s attention
to current anxiety symptoms, as these are indicative
of important clues to the risk of suicide, the response
to treatment and the likely clinical course. There is
also a clear association between MDD+GAD and
mania, which is especially marked with longer dur-
ations of anxiety.
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Table 4. Scores and associations for personality characteristics in the three diagnostic groups, with the duration of generalized anxiety disorder (GAD) set at 6 months (GAD-6) and
1 month (GAD-1) (n=2181)
TPQ
Offspring disorders
MDD alone MDD and other anxiety disorders MDD and GAD-6
Comparison between disorders
No
(n=1911)
Yes
(n=270) Comparison
No
(n=2017)
Yes
(n=164) Comparison
No
(n=2133)
Yes
(n=48) Comparison
MDD and other
anxiety
disorder v. MDD alone
MDD and GAD-6
v. MDD alone
Mean Mean SMD 95% CI Mean Mean SMD 95% CI Mean Mean SMD 95% CI SMD 95% CI SMD 95% CI
Novelty seeking 16.5 17.0 0.12 −0.02 to 0.26 16.5 16.8 0.03 −0.15 to 0.22 16.6 16.3 −0.03 −0.35 to 0.28 −0.14 −0.36 to 0.09 −0.17 −0.52 to 0.18
Harm
avoidance
12.4 13.6 0.17* 0.03 to 0.31 12.3 15.5 0.43* 0.25 to 0.61 12.5 16.3 0.54* 0.22 to 0.87 0.29*† 0.06 to 0.51 0.39* 0.04 to 0.74
Reward
dependence
17.7 18.2 0.11 −0.03 to 0.24 17.7 18.5 0.05 −0.13 to 0.23 17.7 20.3 0.48* 0.21 to 0.75 −0.04 −0.26 to 0.19 0.36* 0.07 to 0.65
TPQ
MDD alone MDD and other anxiety disorders MDD and GAD-1
Comparison between disorders
No
(n=1942)
Yes
(n=239) Comparison
No
(n=2049)
Yes
(n=132) Comparison
No
(n=2070)
Yes
(n=111) Comparison
MDD and other
anxiety
disorder v. MDD alone
MDD and GAD-1
v. MDD alone
Mean Mean SMD 95% CI Mean Mean SMD 95% CI Mean Mean SMD 95% CI SMD 95% CI SMD 95% CI
Novelty
seeking
16.4 17.3 0.19* 0.04 to 0.34 16.5 16.6 −0.01 −0.21 to 0.18 16.6 16.2 −0.07 −0.29 to 0.15 −0.22 −0.47 to 0.02 −0.28*† −0.54 to −0.02
Harm
avoidance
12.5 13.0 0.06 −0.08 to 0.21 12.4 15.3 0.40* 0.20 to 0.60 12.3 16.8 0.65* 0.44 to 0.87 0.36*† 0.12 to 0.61 0.58*† 0.33 to 0.83
Reward
dependence
17.7 18.2 0.10 −0.05 to 0.24 17.7 18.6 0.09 −0.11 to 0.30 17.7 19.2 0.23* 0.02 to 0.44 0.03 −0.22 to 0.27 0.13 −0.12 to 0.38
TPQ, Tridimensional Personality Questionnaire; MDD, major depressive disorder; n, unweighted number of participants; CI, confidence interval; SMD, standardized mean difference
from linear regression based on standardized scores (mean 0, S.D.=1), adjusted for age and sex.
Other anxiety disorders include panic disorder, agoraphobia, social phobia and specific phobia.
Mean values are based on unstandardized scores (standard deviation available upon request).
* Significant at p<0.05.
† Significant at p<0.05 when additionally adjusted for depression severity (number of MDD criteria symptoms).
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